New journal article on the challenges and management of sarcoidosis supported by the Sarcoidosis Research Foundation
CHICAGO, September 15, 2021 / PRNewswire / – The Sarcoidosis Research Foundation (FSR), the leading international non-profit organization dedicated to finding a cure for sarcoidosis and improving the care of patients with sarcoidosis, is delighted to share that a new article focusing on sarcoidosis has been published by the New England Journal of Medicine (NEJM), the most influential authority in the field of medicine in this article, Challenges of sarcoidosis and its management, was written by two of the members of the FSR Scientific Advisory Board (SAB), Elliott Crouser, MD, Ohio State University (President of FSR SAB) and Marjolein Drent, MD, PhD, St. Antonius Hospital.
This scientific article is now considered the new standard in the examination of sarcoidosis.
Sarcoidosis is a rare multisystem inflammatory disease. As a rare disease, sarcoidosis is not well understood and often overlooked. This article details the risk factors associated with the development of sarcoidosis, highlighting the increased risk for African Americans and women. Additionally, this seminal article explores the different clinical and diagnostic features and understanding of the clinical presentation of the disease and provides guidance for faster and more accurate diagnosis. Finally, this review provides a deeper understanding of the clinical presentation, understanding of prognosis, and pathways to better disease management for people living with sarcoidosis.
“Late diagnosis and lack of understanding of sarcoidosis are significant barriers to care for people living with sarcoidosis,” says Marie McGowan, CEO of the Sarcoidosis Research Foundation. “This article will help provide all health care providers with a better understanding of how best to diagnose and treat this disease, which will lead to better patient outcomes.”
Challenges of sarcoidosis and its management is the first scientific article on sarcoidosis published in the NEJM since 2007 and is now considered the new standard of sarcoidosis review. To read the full report, visit https://www.nejm.org/doi/full/10.1056/NEJMra2101555?rss=searchAndBrowse
To learn more about FSR’s sarcoidosis research, please visit www.stopsarcoidosis.org.
Sarcoidosis is a rare inflammatory disease characterized by the formation of granulomas – tiny clusters of inflammatory cells – in one or more organs of the body. Despite increasing advances in research, sarcoidosis remains difficult to diagnose with limited treatment options and no known cure.
About the Sarcoidosis Research Foundation (FSR)
Established in 2000, the Sarcoidosis Research Foundation (FSR) is the leading international non-profit organization dedicated to finding a cure for sarcoidosis and improving care for patients with sarcoidosis. Since its inception, FSR has encouraged more than $ 5 million in sarcoidosis-specific research efforts and has worked diligently to provide resources to thousands of people. For more information and to join our community, visit www.stopsarcoidosis.org.
312-341-0500 ext. 106
SOURCE Foundation for Sarcoidosis Research